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ABSTRACT
Objective To examine the impact of fundoplication on
reflux related hospital admissions for children with
neurological impairment.
Design Retrospective, observational cohort study.
Setting 42 children’s hospitals in the United States.
Participants 3721 children with neurological impairment
born between 2000 and 2005 who had at least one
hospital admission at a study hospital before their
fundoplication.
Intervention Fundoplication.
Main outcome measures Incident rate ratio for reflux
related hospital admissions, defined as the post-
fundoplication admission rate divided by the pre-
fundoplication admission rate.
Results Of the 955285 children born during the study
period, 144749 (15%) had neurological impairment. Of
these, 27720 (19%) were diagnosed as having gastro-
oesophageal reflux disease, of whom 6716 (24%) had a
fundoplication. Of these, 3721 (55%) had at least one
previous hospital admission and were included in the
study cohort. After fundoplication, hospital admissions
decreased for any reflux related cause (incident rate ratio
0.69, 95% confidence interval 0.67 to 0.72; P<0.01),
aspiration pneumonia (0.71, 0.62 to 0.81; P<0.01),
gastro-oesophageal reflux disease (0.60, 0.57 to 0.63;
P<0.01), and mechanical ventilation (0.40, 0.37 to 0.43;
P<0.01), after adjustment for other patient and hospital
related factors that may influence reflux related hospital
admissions. Hospital admissions increased for asthma
(incident rate ratio 1.52, 1.38 to 1.67; P<0.01) and
remained constant for pneumonia (1.07, 0.98 to 1.17;
P=0.16).
Conclusions Children with neurological impairment who
havefundoplicationhadreducedshorttermrefluxrelated
hospital admissions for aspiration pneumonia, gastro-
oesophageal reflux disease, and mechanical ventilation.
However, admissions for pneumonia remained constant
and those for asthma increased after fundoplication.
Comparative effectiveness data for other treatments
(such as gastrojejunal feeding tubes) are unknown.
INTRODUCTION
Aspiration pneumonia is the most common cause of
death in children with severe neurological
impairment.
1-4 These children have dysfunctional
swallowing and gastro-oesophageal reflux disease,
which places them at risk of aspiration pneumonia.
5-7
The most common surgical treatment for medically
refractory gastro-oesophageal reflux disease is the
anti-reflux procedure known as fundoplication. The
surgery involves wrapping part of the stomach around
the lower oesophagus, and this compression of the
oesophagus prevents the stomach contents from
being able to reflux. Fundoplication is the third most
common procedure done by paediatric surgeons.
8
Approximately 40% of paediatric fundoplications in
the United States are done in children with neurologi-
cal impairment.
9
The literature provides some estimates of the effects
offundoplicationinchildrenwithneurologicalimpair-
ment.Complicationsarereportedin4%to39%ofchil-
dren, and mortality is between 1% and 3%.
6810-13
Previous studies have reported contradictory results
of the effectiveness of fundoplication as regards symp-
toms of gastro-oesophageal reflux disease. Outcomes
reported by physicians show abatement of symptoms
in 85%ofchildren.
8Otherstudiesreportrecurrenceof
symptoms of gastro-oesophageal reflux disease after
fundoplicationinupto56%ofchildrenandrecurrence
of aspiration pneumonia in up to 39%.
111415 These ret-
rospective operative case series report outcomes that
aresubjecttobias,andtheyarelimitedbyvariabilityin
loss of patients to follow-up. In addition, they do not
describe explicit selection criteria or specific indica-
tions for the procedure. The lack of high quality evi-
dence for this common clinical scenario hinders both
clinicians and caregivers in deciding whether surgery
would benefit a child.
Multicentre prospective trials evaluating the impact
of comparative therapeutic interventions for gastro-
oesophageal reflux disease in children with neurologi-
cal impairment are being called for, in order to
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spective studies.
16-20 However, the ideal primary out-
come is unclear. Potential outcomes that evaluate the
impact of anti-reflux interventions include resolution
of symptoms, nutritional outcomes, children’s and
caregivers’healthrelatedqualityoflife,complications,
cost, morbidity, and mortality.
192122
Reflux related hospital admission is an objective
and more precise outcome of fundoplication for
gastro-oesophageal reflux disease.
18 Given that these
admissions reflect severe and costly complications of
gastro-oesophageal reflux disease, their assessment
provides a composite assessment of the importance of
the condition inthispopulation, incorporatingmany of
the morbidities. Reflux related hospital admission has
the benefit of being subject to less bias than some other
outcomes,suchasresolutionofsymptoms;italsoaffects
health related quality of life by reducing the time spent
in the hospital for children and their caregivers.
AstudyinasingleUSstatebyGoldinetalexamined
lifetime risk after fundoplication and showed some
reduction in reflux related admissions.
18 We were
able to extend the methods of this study to examine
the impact of fundoplication on reflux related hospital
admissions for children with neurological impairment
within 42 freestanding children’s hospitals across 35
US states. The results of our study provide an estimate
oftheimpactoffirstfundoplicationonseveresequelae
of gastro-oesophageal reflux disease in children with
neurological impairment and inform the development
of a future multicentre clinical trial.
METHODS
Patients
Data for this retrospective observational cohort study
came from the Pediatric Health Information System
administrative database, developed by the Child
Health Corporation of America (Shawnee Mission,
KS), a business alliance of children’s hospitals. The
database contains inpatient demographic, diagnostic,
and procedural data from 42 not for profit, freestand-
ing paediatric hospitals in the United States. Thomson
Reuters (Evanston, IL) manages the data warehouse
functionforthedatabase.Dataaresubjectedtoseveral
checks of reliability and validity and processed into
dataqualityreports.Patientsaretrackedforrepeathos-
pital admissions at the same children’s hospital by use
of a unique identifier.
Study population
We used the following inclusion criteria to create the
cohort: birth date during the study enrolment period
(2000-5), at least one admission to any of the 42
Pediatric Health Information System hospitals, and
an ICD-9-CM (international classification of diseases,
9th revision, clinical modification) diagnostic code for
neurological impairment. We then followed this
cohort and included patients who had a diagnosis
code for gastro-oesophageal reflux disease (530.11,
5301.81) and a procedure code for fundoplication
(44.66, 44.67). We created the cohort in this manner
toensurethatwewouldcapturethefirstfundoplication.
We followed the cohort for one year after the first
fundoplicationto capture reflux related hospital admis-
sions. We used the same codes for reflux related
admissions on the cohort before fundoplication. We
excluded children with neurological impairment and
gastro-oesophageal reflux disease who did not have at
least one hospital admission before the fundoplication
for two reasons: their care was not solely based at the
PediatricHealthInformationSystemhospital,andthey
may constitute a different patient population; and our
methods did not allow for a zero pre-fundoplication
admission rate. For subanalyses, we divided the study
cohort into two groups: childrenwithprevious hospital
admissionsthatwerenotrelatedtorefluxandthosewith
at least one previous reflux related admissions.
Patients’ characteristics
Demographics—Demographic characteristics included
sex, ethnicity (non-Hispanic white, black, Hispanic,
Asian, and other), payer (government, private, other),
discharge disposition (home, died, other), and age
(<3 months, 3 to <6 months, 6 to <12 months, 12 to
<18 months, 18 to <36 months, ≥36 months) on the
basis of observation of the distribution of cases for
this young cohort (<7 years) and published data.
18
Neurological impairment—We defined neurological
impairmentasstaticorprogressive,centraland/orper-
ipheralneurologicaldiagnosesassociatedwithchronic
functional and/or intellectual impairment. We deter-
mined ICD-9-CM codes for neurological impairment
from previous studies (Adam Goldin, personal com-
munication,2008)andthetabularindexofICD-9-CM
coding.
9181922Neurologicalimpairmentincludeddiag-
noses such as cerebral palsy, hydrocephalus, leukody-
strophy, and epilepsy.
Complex chronic conditions—We defined complex
chronic conditions as respiratory, renal, gastro-
intestinal, metabolic, haematological, congenital or
Birth cohort (2000-5) (n=955 285)
No neurological code
(n=810 536, 84.8%)
At least 1 neurological code
(n=144 749, 15.2%)
No gastro-oesophageal reflux
disease (n=117 029, 80.8%)
Gastro-oesophageal reflux
disease (n=27 720, 19.2%)
No fundoplication 
(n=21 004, 75.7%)
Fundoplication
(n=6716, 24.3%)
Alive (n=6452, 95.9%) Died (n=264, 4.1%)
With previous visit
(n=3721, 57.7%)
Without previous visit
(n=2731, 42.3%)
Fig 1 | Study cohort.
RESEARCH
page 2 of 8 BMJ | ONLINE FIRST | bmj.comgenetic defect, malignancy, and cardiovascular diag-
noses expected to last longer than 12 months that
involve either several different organ systems or one
organ system severely enough to need specialty pae-
diatric care and admission to hospital.
2324 Complex
chronic conditionsare ICD-9-CMbased andintended
for use with paediatric administrative hospital
admission data. We did not use the neuromuscular
category, as the study cohort was assembled with neu-
rological impairment as a criterion for inclusion.
Tracheostomyandupperairwayanomalies—Otherchar-
acteristicsthatmayaffectrefluxrelatedhospitaladmis-
sions are tracheostomy and upper airway anomalies.
We defined tracheostomy as ICD-9-CM procedure
codes 31.1, 31.2, 317.4, 317.5, 96.55, and 97.23 or
diagnoses codes 519.00, 519.01, 519.02, 519.09,
v44.0,andv55.0.
2526Wedefinedupperairwayanoma-
lies as ICD-9-CM diagnoses codes 744.4x, 744.8x,
744.9, 747.21, 748.0, 748.2-4, 749.0x, 749.2x, 759.7,
and 759.89.
27 We analysed tracheostomy and upper
airway anomalies as present or absent for the patient
during the study period.
Gastrostomy tube—Gastrostomy feeding tubes are
commoninthispopulation.
28Wedefinedgastrostomy
tubes by using ICD-9-CM procedure codes 43.0,
43.19, 43.11, 43.1, and 97.02 or ICD-9-CM diagnoses
codes v44.1, v55.1, and 536.4x. We analysed them as
placed before the fundoplication, during the fundopli-
cation procedure, both, or neither. We were unable to
accuratelyidentifygastrojejunalfeedingtubes(another
anti-refluxprocedure)inthePediatricHealthInforma-
tion System database.
Hospitals’ characteristics
Hospitals’ characteristics analysed were regional loca-
tion (north east, south, central, west), average annual
hospital volume of fundoplication during the study
period, and percentage of fundoplication for children
admitted with neurological impairment and gastro-
oesophageal reflux disease within each study hospital.
We categorised the average annual hospital volume
into quarters. We measured the percentage of fundo-
plication for the study population within hospitals to
account for variability of indication for the procedure
and institutional practices.
Outcomes
Wedefinedrefluxrelatedhospitaladmissionasadmis-
sionforoesophagitis(530.1,530.10,530.12,530.19)or
gastro-oesophageal reflux disease (530.11, 530.81),
aspiration pneumonia (507.0), pneumonia (480-486),
asthma (493), or mechanical ventilation (96.7, 96.70,
96.71,96.72).
1829Wechosetheoutcomesofadmission
for oesophagitis, gastro-oesophageal reflux disease,
and aspiration pneumonia as a complication of failure
to treat gastro-oesophageal reflux disease. We chose
the outcomes of admission for pneumonia, asthma,
and mechanical ventilation for three reasons: they
comprise a group of major respiratory problems that
children with severe neurological impairment often
encounter
3031; distinguishing aspiration pneumonia
from another lower respiratory infection or event is
difficult, unless it is clinically obvious (such as a wit-
nessed aspiration event); and a reduction in mechani-
cal ventilation rates, whatever the cause, is a more
objective measure of the impact of fundoplication on
this study cohort.
Table 1 |Comparison of patients’ characteristics between children with and without previous
reflux related hospital admissions. Values are numbers (percentages)
Characteristic Total (n=3721)
History of reflux related admission
Yes (n=2532) No (n=1189) P value
Age:
<3 months 337 (9.2) 147 (5.8) 190 (16.0)
<0.001
3 to <6 months 538 (14.5) 321 (12.7) 217 (18.3)
6 months to <1 year 894 (24.0) 627 (24.8) 267 (22.5)
1 to <1.5 years 583 (15.7) 426 (16.8) 157 (13.2)
1.5 to <3 years 883 (23.7) 648 (25.6) 235 (19.8)
≥3 years 486 (13.1) 363 (14.3) 123 (10.3)
Male sex 2125 (57.1) 1469 (58.0) 656 (55.2) 0.1020
Ethnicity:
Non-Hispanic white 1918 (53.9) 1342 (55.3) 576 (50.8)
0.0696
Black 658 (18.5) 424 (17.5) 234 (20.6)
Hispanic 619 (17.4) 423 (17.4) 196 (17.3)
Asian 76 (2.1) 50 (2.1) 26 (2.3)
Other 291 (8.2) 189 (7.8) 102 (9.0)
Insurance:
Government 2118 (56.9) 1437 (56.8) 681 (57.3)
0.2336 Private 950 (25.5) 634 (25.0) 316 (26.6)
Other 652 (17.5) 461 (18.2) 191 (16.1)
Discharge disposition:
Home 3246 (87.4) 2220 (87.9) 1026 (86.4)
0.2711 Died 41 (1.1) 24 (1.0) 17 (1.4)
Other 428 (11.5) 283 (11.2) 145 (12.2)
Median length of stay:
1-5 days 1389 (37.3) 980 (38.7) 409 (34.4)
<0.001
6-10 days 621 (16.7) 454 (17.9) 167 (14.1)
11-15 days 382 (10.3) 272 (10.7) 110 (9.3)
≥16 days 1329 (35.7) 826 (32.6) 503 (42.3)
Complex chronic conditions:
Cardiovascular 1699 (45.7) 1187 (46.9) 512 (43.1) 0.0292
Respiratory 1319 (35.5) 989 (39.1) 330 (27.8) <0.001
Renal 308 (8.9) 206 (8.1) 102 (8.6) 0.6476
Gastrointestinal 260 (7.0) 187 (7.4) 73 (6.1) 0.1645
Haematological or
immunological
145 (3.9) 102 (4.0) 43 (3.6) 0.5449
Metabolic 290 (7.8) 209 (8.3) 81 (6.8) 0.1260
Congenital or genetic 1483 (39.9) 1068 (42.2) 415 (34.9) <0.001
Malignancy 167 (4.5) 109 (4.3) 58 (4.9) 0.4310
Gastrostomy tube:
Previously 240 (6.5) 192 (7.6) 48 (4.0)
<0.001
During fundoplication
procedure
2368 (63.6) 1451 (57.3) 917 (77.1)
Both 873 (23.5) 718 (28.4) 155 (13.0)
Never 240 (6.5) 171 (6.8) 69 (5.8)
Ever had a tracheostomy 631 (17.0) 448 (17.7) 183 (15.4) 0.0809
Presence of upper airway
anomaly
1243 (33.4) 912 (36.0) 331 (27.8) <0.001
RESEARCH
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We compared rates of reflux related hospital admis-
sion before and after fundoplication for the entire
cohort. We truncated all outcomes to one year’s fol-
low-up. For the main analyses, we excluded patients
whodiedaftertheirfundoplication,inordertoprovide
complete one year follow-up data. We excluded the
admission for the fundoplication in both the before
and after fundoplication admission rate data.
Rates of reflux related hospital admissions per child
year before and after fundoplication were calculated
directly. We calculated the “before” period as elapsed
daysoflifeduringthe studyperiodfrombirthuntilthe
admission for the first fundoplication. The “after” per-
iod was one year post-fundoplication.
18 We used Pois-
sonregressionmodellingforallanalyses.Wefoundno
evidence of overdispersion of data. We calculated
unadjusted incident rate ratios by dividing the post-
fundoplication reflux related admission rate by the
pre-fundoplication rate. An incident rate ratio greater
than 1 occurs when the post-fundoplication rate is
greater than the pre-fundoplication rate (for example,
with a harmful effect of fundoplication), a ratio of 1
indicates no differences in rates, and a ratio of less
than 1 occurs when the post-fundoplication rate is
lower than the pre-fundoplication rate (for example,
with a protective effect of fundoplication). We calcu-
lated bivariate adjusted incident rate ratios while
accounting for patients’ characteristics and hospital
level covariates individually.
Multivariate Poisson modelling included the signifi-
cant bivariate variables and accounted for hospital
clustering by using hierarchical models. As patient’s
age was the most influential covariate in the adjusted
model, we treated age as a stratification factor and
derived individual Poisson regression models for
eachagegroup.Wealsodidthefollowingsubanalyses:
cohort restriction to children with a “before” period of
atleastoneyearandcohortexpansiontochildrenwho
died in the one year after the fundoplication.
RESULTS
Of the 955285 children eligible during the study per-
iod, 144749 (15%) had neurological impairment. Of
these, 27720 (19%) developed gastro-oesophageal
reflux disease and 6716 (24%) had a fundoplication.
Ofthese,3721(55%)hadatleastoneprevioushospital
admissionandwereincludedinthestudycohort(fig1).
At the time of their first fundoplication, 1769 (48%)
were aged younger than 12 months, 1596 (42.9%)
were female, 1918/3562 (53.9%) were white non-
Hispanic, 658 (18.5%) were black, 619 (17.4%) were
Hispanic, and 2118 (56.9%) used government insur-
ance (table 1). After fundoplication, 3246/3715
(87.4%) were discharged home and 41 (1.1%) died.
The most common reasons for neurological impair-
ment were seizures (1777, 47.8%), brain or spinal cord
abnormalities(1225,32.9%),geneticconditions(1063,
28.6%), and cerebral palsy (990, 26.6%). At least one
othercomorbidchronic conditionwaspresentin 2863
(76.9%) children. A gastrostomy tube was placed dur-
ing the fundoplication procedure in 2368 (63.6%)
patients; 631 (17.0%) patients had a tracheostomy,
and 1243 (33.4%) had an upper airway anomaly
(table 1). The percentage of fundoplication done on
the study cohort within study hospitals ranged from
2.2% to 26.0% (table 2).
Fortheentirecohort,theunadjustedpre-fundoplica-
tion rate (per child year) for any reflux related hospital
admission was 1.63 (95% confidence interval 1.45 to
1.81). The post-fundoplication rate for any reflux
relatedadmissionwas1.63 (1.43to 1.81).The incident
rate ratio was 0.98 (0.95 to 1.02; P=0.3443). The unad-
justed rates for aspiration pneumonia were 0.12 (0.10
to 0.14) pre-fundoplication and 0.1 (0.08 to 0.13) post-
fundoplication;theincidentrateratiowas0.86(0.76to
0.97; P=0.138) (fig 2).
For the entire cohort, the adjusted pre-fundoplica-
tion and post-fundoplication rates (per child year)
decreased for any reflux related hospital admission
(incident rate ratio 0.69, 0.67 to 0.72; P<0.01), aspira-
tion pneumonia (0.71, 0.62 to 0.81; P<0.01), gastro-
oesophageal reflux disease (0.60, 0.57 to 0.63;
P<0.01), and mechanical ventilation (0.40, 0.37 to
0.43; P<0.01). Hospital admissions increased for
asthma (incident rate ratio 1.52, 1.38 to 1.67; P<0.01)
and remained constant for pneumonia (1.07, 0.98 to
1.17; P=0.16) (fig 2).
When we specifically examined age by category in
the Poisson regressionmodels,hospital admissionsfor
any reflux related cause decreased in all age groups,
except those older than 36 months in whom admis-
sions remained constant (table 3). We did not analyse
admissionsforoesophagitiswithinagegroupsowingto
sparseobservations.Forpatientsunder12monthsold,
the adjusted incident rate ratio was significantly less
than 1 for aspiration pneumonia, gastro-oesophageal
reflux disease, and mechanical ventilation but was
either constant or greater than 1 (the post-fundoplica-
tion rate was higher than the pre-fundoplication rate)
forasthmaandpneumonia.Theageeffectwaslesscon-
sistent over the age of 12 months, depending on the
Table 2 |Comparison of hospitals’ characteristics between children with and without previous
reflux related hospital admission
Census region:
North east 352 (9.5) 256 (10.1) 96 (8.1)
0.0112
South 1624 (43.6) 1063 (42.0) 561 (47.2)
North central 996 (26.8) 701 (27.7) 295 (24.8)
West 749 (20.1) 512 (20.2) 237 (19.9)
AnnualNooffundoplications:
<40 805 (21.6) 584 (23.1) 221 (18.6)
<0.001 40-80 898 (24.1) 631 (24.9) 267 (22.5)
>80 2020 (54.3) 1317 (52.0) 701 (59.0)
Fundoplication for patients
with neurological impairment
and GERD (%)
<10 1049 (28.2) 790 (31.2) 259 (21.8)
<0.001 10-20 1790 (48.1) 1197 (47.3) 593 (49.9)
>20 882 (23.7) 545 (21.5) 337 (28.3)
GERD=gastro-oesophageal reflux disease.
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Subanalyses restricting the cohort to children with a
“before” period of at least one year and expanding the
cohort to children who died in the one year after the
fundoplication gave similar findings to those for the
entire cohort.
DISCUSSION
We observed a short term reduction in reflux related
hospital admissions in this large multicentre cohort
study of children with neurological impairment and
gastro-oesophageal reflux disease who had a first fun-
doplication. A reduction in hospital admissions for
aspiration pneumonia, gastro-oesophageal reflux dis-
ease, and mechanical ventilation occurred. However,
admissions for pneumonia and asthma either
remained constant or increased after fundoplication.
The reduction in reflux related admissions was depen-
dent on the age at which children with neurological
impairment had their fundoplication.
Comparison with other studies
These findings are similar in two ways to those of
Goldin et al, who evaluated reflux related hospital
admissions before and after all fundoplications in the
stateofWashingtonbetween1987and2001.
18Despite
differences in age of the study cohorts, reflux related
admissions for all combined conditions were lower
after fundoplication in younger children (age <1 year
) with developmental delay. The magnitude of this
effect across age categories— incident rate ratio 0.5
(0.4 to 0.63) for those under 12 months, 0.54 (0.41 to
0.71) for those between 12 and 48 months, and 1.38
(1.03 to 1.85) for those older than 48 months—was
similar to our findings.
Our findings also differ from those of Goldin et al,
who reported no difference in rates of hospital admis-
sion for aspiration pneumonia before and after fundo-
plication among children with developmental delay in
any age group. Our findings differ from those of this
seminal study for several possible reasons. Children
with neurological impairment may experience differ-
entconsequencesofgastro-oesophagealrefluxdisease,
suchasaspirationpneumonia,astheygrowolder.The
underlying reason for neurological impairment may
makefundoplicationalessdesirableproceduretocon-
trolaspirationpneumoniaoverthelifeofthechild.The
study by Goldin et al had more children with neurolo-
gical impairment who were older and followed for
their lifetime, whereas our study, by design, focused
on a young cohort followed for one year, in order to
capture their first fundoplication. Goldin et al exam-
ined data from a single state, whereas our study
included data from 35 US states. This multi-state ana-
lysismayreflectdifferencesbeyondregionalcare,such
asdifferentselectionofpatients,whichmayhaveinflu-
enced the results.
Other studies have largely focused on other less
objective outcomes such as control of symptoms and
reporting of complications after fundoplication.
610-13
Fonkulsrud et al reported in the largest case series to
date (more than 7400 fundoplications) that outcomes
reportedbyphysiciansfromsevenchildren’shospitals
over a20 yearperioddescriberesolutionofsymptoms
in 85% of children with neurological impairment.
8
Other smaller surgical case series describe less reduc-
tion in symptoms after fundoplication in children with
neurological impairment.
111415
Lasser et al published nationally weighted US data
showing that fundoplications for children with neuro-
logical impairment decreased between 1996 and 2003
andthatthesechildrenhadfundoplicationat5yearsof
age or less.
9 Although this study was unable to follow
the children over time, the results are similar to ours,
reflecting a young age for first fundoplication in chil-
dren with neurological impairment. One other study
examined hospital admissions before and after fundo-
plication in a small sample and, as in Goldin et al’s
study, found a reduction in admissions for children
with neurological impairment.
1832
Strengths and limitations of study
The strengths of this study include extending pre-
viouslypublishedmethodsfromGoldinetaltoalarger
samplefromseveralUSstates,thusincreasingthegen-
eralisability of the results. Our outcome was more
objectivethanthoseofseveralotherstudiesexamining
theeffectivenessoffundoplicationinthispopulationof
patients.Westudiedchildrenwhohadatleastonevisit
to the study hospital before their first fundoplication,
thus reducing potential selection bias.
Ourstudyhasseverallimitationsinherentintheana-
lysis of existing databases. The diagnoses of gastro-
oesophageal reflux disease (for our inclusion criteria)
and reflux related hospital admission (our outcomes)
were based on ICD-9-CM codes. We recognise that
coding differences exist among hospitals,
3334 but we
have no reason to suspect systematic bias before and
after the fundoplication that could have affected our
admissionrates.ThePediatricHealthInformationSys-
tem does not contain clinical data to ascertain
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Fig 2 | Unadjusted and adjusted incident rate ratios (post-
fundoplication rate divided by pre-fundoplication rate), with
95% CIs, for reflux related hospital admissions (RRH).
GERD=gastro-oesophageal reflux disease
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andrefluxrelatedadmission.Clinicaldataareessential
to substantiate the diagnosis of gastro-oesophageal
reflux disease and the diagnoses that comprise reflux
related hospital admissions, but we could not look at
thisinouradministrativedatabasestudy.Forexample,
we could not determine if aspiration pneumonia after
fundoplication was related to primary aspiration (for
example, of secretions) or secondary aspiration (such
as refluxed gastric contents). We could not examine
howthediagnosisofgastro-oesophagealrefluxdisease
was made for these children (clinical, radiographic,
endoscopic), as the database does not contain outpati-
ent or community data. Indications for fundoplication
were unavailable. We could not accurately identify
patients who had a different anti-reflux procedure,
such as gastrojejunal feeding tubes, which could have
influenced the results.
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The reduction in hospital admissions may have
represented physicians’ bias in not labelling gastro-
oesophageal reflux disease or aspiration pneumonia
for the post-fundoplication respiratory related admis-
sions.Physiciansmayhavebeenmorelikelytobelieve
that the patienthadasthmaor pneumonia.This poten-
tial systematic bias cannot be determined in our study,
but we believe that the reduction in admissions for
mechanical ventilation make this possibility more
remote. Our study may have overestimated the effect
offundoplicationonrefluxrelatedhospitaladmissions
for very young children, as their pre-fundoplication
rates may be lower than those of children who were
followedforalongerperiodoftimebeforetheirfundo-
plication. The subanalysis of patients followed for at
least one year pre-fundoplication was similar to the
results for the entire cohort. Early intervention in chil-
dren aged under 1 year may be, in part, natural recov-
ery as opposed to the effects of treatments. By
including age in the overall model, we attempted to
adjust for secular trends, but residual confounding
may still exist. We may have underestimated the mor-
bidity associated with this procedure, as our definition
of reflux related hospital admission did not include
admissions for operative complications. We restricted
ouranalysestopatientsbornduringthestudyperiodto
capture all procedures done in the respective chil-
dren’shospitals.Thismayhaverestrictedthegenerali-
sability of our results to fundoplication in older
children with neurological impairment and gastro-
oesophageal reflux disease. Clinically, we found that
most of these procedures were first done in younger
children (unless the neurological impairment was
acquired—for example, traumatic brain injury in
older children), which was similar to observations by
Lasser et al.
9 However, we have limited data on the
effectiveness of fundoplication in a large neonatal
population, as our study design required a hospital
admission to a study hospital before the fundoplica-
tion.
Patients may have been admitted to a non-Pediatric
HealthInformationSystemhospitalandthusmissedin
the outcome of another hospital admission in our
study. However, in our experience, children with neu-
rological impairment and gastro-oesophageal reflux
diseasehavingfundoplicationreceivethevastmajority
of their inpatient care at their local children’s hospital.
Thisstudydoesnotcovertheeffectivenessoffundopli-
cationinthe2731patientswhowereexcludedbecause
theydidnothaveapreviousadmission.Manypatients
with neurological impairment and medically refrac-
tory gastro-oesophageal reflux disease are referred to
children’shospitalsforevaluationforafundoplication.
Table 3 |Age specific models for reflux related hospital
admissions, with unadjusted and adjusted incident rate
ratios
Age at fundoplication
Incidence rate ratio (95% CI)
Unadjusted Adjusted
Aspiration pneumonia
0 to <3 months 0.17 (0.08 to 0.33) 0.16 (0.08 to 0.33)
3 to <6 months 0.37 (0.25 to 0.55) 0.41 (0.27 to 0.61)
6 to <12 months 0.60 (0.47 to 0.78) 0.61 (0.46 to 0.79)
12 months to <18 months 0.86 (0.66 to 1.13) 0.87 (0.66 to 1.15)
18 months to <3 years 0.74 (0.58 to 0.94) 0.75 (0.59 to 0.96)
≥3 years 1.31 (0.94 to 1.82) 1.35 (0.97 to 1.88)
Gastro-oesophageal reflux disease
0 to <3 months 0.27 (0.22 to 0.34) 0.27 (0.21 to 0.33)
3 to <6 months 0.39 (0.35 to 0.45) 0.40 (0.35 to 0.46)
6 to <12 months 0.57 (0.51 to 0.62) 0.55 (0.50 to 0.61)
12 months to <18 months 0.70 (0.62 to 0.79) 0.70 (0.62 to 0.79)
18 months to <3 years 0.74 (0.66 to 0.82) 0.75 (0.67 to 0.83)
≥3 years 1.12 (0.94 to 1.32) 1.10 (0.93 to 1.31)
Mechanical ventilation
0 to <3 months 0.17 (0.13 to 0.22) 0.17 (0.13 to 0.23)
3 to <6 months 0.25 (0.21 to 0.29) 0.25 (0.21 to 0.30)
6 to <12 months 0.41 (0.36 to 0.47) 0.41 (0.36 to 0.47)
12 months to <18 months 0.56 (0.46 to 0.67) 0.56 (0.46 to 0.68)
18 months to <3 years 0.54 (0.44 to 0.65) 0.54 (0.44 to 0.65)
≥3 years 1.21 (0.91 to 1.60) 1.18 (0.89 to 1.57)
Pneumonia (non-aspiration)
0 to <3 months 1.63 (0.82 to 3.26) 1.77 (0.85 to 3.67)
3 to <6 months 0.95 (0.71 to 1.26) 0.95 (0.71 to 1.27)
6 to <12 months 1.03 (0.88 to 1.22) 1.04 (0.87 to 1.23)
12 months to <18 months 0.82 (0.67 to 1.00) 0.82 (0.67 to 1.00)
18 months to <3 years 1.02 (0.86 to 1.21) 1.02 (0.85 to 1.21)
≥3 years 2.11 (1.71 to 2.6) 2.14 (1.73 to 2.64)
Asthma
0 to <3 months 1.98 (0.71 to 5.52) 1.79 (0.64 to 5.05)
3 to <6 months 1.56 (0.99 to 2.45) 1.70 (1.05 to 2.76)
6 to <12 months 2.59 (2.04 to 3.29) 2.84 (2.19 to 3.67)
12 months to <18 months 1.57 (1.28 to 1.91) 1.49 (1.22 to 1.83)
18 months to <3 years 1.24 (1.07 to 1.44) 1.25 (1.08 to 1.46)
≥3 years 1.70 (1.37 to 2.12) 1.63 (1.30 to 2.03)
Any reflux related hospital admission
0 to <3 months 0.30 (0.26 to 0.35) 0.29 (0.25 to 0.34)
3 to <6 months 0.40 (0.37 to 0.44) 0.41 (0.38 to 0.45)
6 to <12 months 0.66 (0.62 to 0.70) 0.66 (0.62 to 0.70)
12 months to <18 months 0.79 (0.73 to 0.85) 0.78 (0.72 to 0.85)
18 months to <3 years 0.81 (0.76 to 0.87) 0.82 (0.77 to 0.88)
≥3 years 1.40 (1.27 to 1.55) 1.39 (1.26 to 1.54)
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Pediatric Health Information System database limited
our ability to assess whether this cohort’s outcomes
were better, no different, or worse than those of the
included children.
We could not make adjustments for functional lim-
itations owing to lack of information in the database.
Wedidnotmeasureotherimportantoutcomes,suchas
health related quality of life of either the caregiver or
thechildovertime,
22noranycomplicationsorthecost
of the fundoplication or resultant inpatient care, as
these were beyond the scope of our study.
Conclusions and policy implications
We observed a short term reduction in reflux related
hospital admission in this large multicentre cohort
study of children with neurological impairment and
gastro-oesophagealrefluxdiseasewhohadfundoplica-
tion. Reduced admission is certainly beneficial to chil-
dren, their family, and the hospitals that serve them.
However, these admissions are one component in a
series of outcomes that providers may discuss with
families of children with neurological impairment.
Demonstrable reduction in symptoms, improvement
in the child’s and caregivers’ health related quality of
life,andreductionincomplicationsshouldalsobecon-
sidered. Multicentre prospective comparative trials
(forexample,foranti-refluxproceduressuchasgastro-
jejunal feeding tubes versus fundoplication) should be
consideredwiththeseoutcomes,inordertodetermine
the true efficacy of anti-reflux procedures in reducing
thecomplicationsofgastro-oesophagealrefluxdisease
in children with neurological impairment. Longer
termoutcomesneedtobestudied,astherisksandben-
efits for an intervention may change over time. These
studiesmay helpto definesubsetsofpatientswhomay
havemoreorlessbenefitfromananti-refluxoperation
or who may be more or less disposed to have compli-
cations. Conflicting results may emerge, making fun-
doplication an intervention that requires the families’
and clinicians’ complete understanding and partner-
ship before embarking along a particular treatment
pathway.
In conclusion, children with neurological impair-
ment and gastro-oesophageal reflux disease who have
fundoplication experienced reduced hospital admis-
sions for aspiration pneumonia, gastro-oesophageal
reflux disease, and mechanical ventilation. However,
admissions for pneumonia remained constant and
those for asthma increased after fundoplication. Com-
parativeeffectivenessdataforothertreatments(suchas
gastrojejunal feeding tubes) are unknown.
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